Efficacy and safety of galcanezumab for cluster headache preventive treatment: a systematic review and meta-analysis

Simple item page
dc.contributor.authorMarina Barbosa da Silva
dc.contributor.authorDomênica Baroni Coelho de Oliveira Ferreira
dc.contributor.authorCristian D. Mendieta
dc.contributor.authorH. Silva
dc.contributor.authorLívia Aguiar Nogueira-Rosa
dc.contributor.authorNathalia Moraes-Figueiredo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:02:55Z
dc.date.available2026-03-22T21:02:55Z
dc.date.issued2024
dc.descriptionCitaciones: 4
dc.description.abstractThis meta-analysis suggests that galcanezumab is effective in reducing the number of CH attacks and can be considered a safe medication.
dc.identifier.doi10.1080/01616412.2024.2440022
dc.identifier.urihttps://doi.org/10.1080/01616412.2024.2440022
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85621
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.ispartofNeurological Research
dc.sourceCentro Universitário Barão de Mauá
dc.subjectCluster headache
dc.subjectMedicine
dc.subjectCalcitonin gene-related peptide
dc.subjectMechanism (biology)
dc.subjectCluster (spacecraft)
dc.subjectMonoclonal antibody
dc.subjectMeta-analysis
dc.subjectPharmacology
dc.subjectBioinformatics
dc.titleEfficacy and safety of galcanezumab for cluster headache preventive treatment: a systematic review and meta-analysis
dc.typereview

Files

Collections

Artículo Científico Publicado